美对华赤藓糖醇“双反”终裁落地！税率从超450%骤降至约94%仍处高位 三元生物如何破局？

Core Viewpoint - The trade friction between China and the U.S. regarding erythritol has reached a critical point, with significant tariffs imposed on Chinese products, impacting market access and prompting companies to diversify their strategies to mitigate risks [2][3][4]. Group 1: Tariff Implications - The U.S. Department of Commerce announced final anti-dumping and countervailing duties on Chinese erythritol products, with a countervailing duty of 8.63% and an anti-dumping duty of 84.95%, resulting in a combined tariff of 93.58% [2][3]. - This combined tariff, although reduced from a previous rate of 450.64%, still poses a significant barrier for Chinese companies seeking to enter the U.S. market [2][3][4]. Group 2: Market Dynamics - The initial investigation began in December 2024, initiated by U.S. producer Cargill, leading to a significant drop in Chinese erythritol exports to the U.S. due to high tariffs [3]. - The competitive landscape in the sugar substitute industry remains challenging, with nearly 94% tariffs creating a heavy burden for companies relying solely on raw material exports [4]. Group 3: Strategic Responses - In response to the tariffs, the company is accelerating the production of allulose, a promising new product, with plans for a 20,000-ton annual production capacity, which is expected to meet growing demand in the U.S. and other markets [7][8]. - The company is also diversifying its product offerings by developing high-value products such as rebaudioside M and sweet tea glycosides, as well as cosmetic raw materials, to reduce reliance on erythritol [8]. - To counteract the challenges in the U.S. market, the company is expanding into neighboring markets like Canada and Mexico, and is also addressing raw material cost issues by building a corn processing line [8].